Home » Topics » BioWorld Science

BioWorld Science
RSS

DSMB recommends continuation of phase II study of SENS-111 in acute unilateral vestibulopathy

May 15, 2019

Sienna reports biopsy data from phase IIb study of SNA-120 for psoriasis

May 15, 2019

Encouraging phase I data reported for dAd5GNE anti-cocaine vaccine

May 15, 2019

Sanofi doses first patient in phase IIb study of SAR-442168 for relapsing MS

May 15, 2019

FDA approves Bavencio with Inlyta for advanced renal cell carcinoma

May 15, 2019

Mutation in ROBO1 gene tied to development of CPHD

May 15, 2019

Precision BioSciences describes ARCUS gene editing strategy for hepatitis B

May 15, 2019

Alzheimer's candidate PRI-002 completes phase I testing

May 15, 2019

AEA, PEA and OEA as promising novel biomarkers for autism spectrum disorder

May 15, 2019

Flotillin-1/2 as a novel target in patients with CNS inflammatory conditions

May 15, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...